Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: BARRY ALLEN who wrote (2922)	7/31/1999 7:35:00 PM
From: nab	Read Replies (1) \| Respond to of 4140

You know what is also strange? I was trading SNRS on 7/27 when the following release from Avalon was posted and the price had never reached $4.00 as stated in the news, it was if I remember correctly only $3.50 and I wondered what kind of scheme was being laid and played... <begin quote> July 27, 1999 11:32 Avalon Research Group Inc. Changes Sell/Sell Short Sunrise Technologies International Recommendation To Neutral BOCA RATON, Fla., July 27 /PRNewswire/ -- The following is being issued by Avalon Research Group Inc., a member of the National Association of Securities Dealers, CRD number 39815: Avalon Research Group Inc., an institutional research firm and registered broker/dealer changes its sell/sell short opinion for Sunrise Technologies International, Inc. (Nasdaq: SNRS) to neutral. In a research update following the SNRS's unsuccessful appearance at the July 22, 1999 FDA Ophthalmic Devices Panel review, Avalon recommended that its investors cover their short sale positions. Avalon's target price of $4.00 was exceeded. <end quote> Very Strange Indeed... Where is that "SEC butt microscope" when you need it? NB

To: BARRY ALLEN who wrote (2922)	7/31/1999 7:42:00 PM
From: nab	Respond to of 4140

oops, figured it out! the downward price target... But I still agree that the SNRS technology is not only impressive, but a valid "breakthrough" in Opthalmological Science and Treatment! That's my opinion! NB